The COVID-19 pandemic is negatively impacting patients with non-COVID-related disease and providers are being faced with challenges in delivering ongoing care to patients with chronic health conditions, such as cancer. This article provides recommendations for alternative treatment for lung cancer patients undergoing chemotherapy and other targeted therapies. The authors also suggest approaches to managing treatment-related adverse events outside the hospital to reduce virus exposure among an immunocompromised population.